National Pension Service Neurocrine Biosciences Inc Transaction History

National Pension Service

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$130.86 - $143.19 $22.8 Million - $24.9 Million	-174,150 Reduced 99.9%	180 $24,000
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $22.7 Million - $25 Million	174,150 Added 96750.0%	174,330 $24 Million
Q2 2023 Aug 15, 2023	SELL	$89.53 - $104.87 $1.93 Million - $2.27 Million	-21,611 Reduced 99.17%	180 $16,000
Q1 2023 May 11, 2023	BUY	$94.11 - $123.02 $2.05 Million - $2.68 Million	21,791 New	21,791 $2.21 Million
Q3 2021 Nov 18, 2021	SELL	$86.18 - $99.03 $861 - $990	-10 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$89.43 - $102.27 $178 - $204	2 Added 25.0%	10 $1,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $61,736 - $84,177	-705 Reduced 98.88%	8 $1,000
Q4 2020 Feb 19, 2021	BUY	$86.91 - $108.33 $20,250 - $25,240	233 Added 48.54%	713 $68,000
Q2 2020 Aug 11, 2020	BUY	$85.09 - $130.36 $40,843 - $62,572	480 New	480 $59,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

Stay updated on National Pension Service with notifications on news.